The cost of caring for patients with inflammatory bowel disease (IBD) continues to increase
worldwide. The cause is not only a steady increase in the prevalence of Crohn's disease …

Background Inflammatory bowel disease (IBD) places a significant burden on health-care
systems because of its chronicity and need for expensive therapies and surgery. With …

Direct health care costs of illness reflect the costs of medically necessary services and
treatments paid for by public and private payers, including hospital-based care, outpatient …

Background Knowledge of the cost of illness of inflammatory bowel disease (IBD) is
essential for health policy makers worldwide. Aim To assess the cost of illness of IBD from …

Background The burden of inflammatory bowel disease (IBD) is rising globally, with
substantial variation in levels and trends of disease in different countries and regions …

The inflammatory bowel diseases ulcerative colitis and Crohn's disease are chronic,
relapsing disorders of the gastrointestinal tract. Collectively, these conditions can result in …

Background The burden of inflammatory bowel disease (IBD) is rising globally, with
substantial variation in levels and trends of disease in different countries and regions …

Background and aims: The potentially high costs of care associated with inflammatory bowel
disease (IBD) are recognised but we have little knowledge of the scale, profile, or …

OBJECTIVES: The prevalence of inflammatory bowel disease (IBD) is increasing. The total
direct costs of IBD have not been assessed on a population-wide level in the era of biologic …

New data suggest that incidence and prevalence of inflammatory bowel diseases [IBD] are
still increasing worldwide, and approximately 0.2% of the European population suffer from …